|

Cangrelor Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

  • University of Florida1
  • IRCCS San Raffaele1

Indications

  • Heart Disease2
  • Platelet Dysfunction1
  • Extracorporeal Membrane Oxygenation Complication1
  • Cardiogenic Shock1
  • Coronary Arterial Disease (CAD)1

Other1 trial

Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO
Phase 2

Jacksonville, Florida1 trial

The Bridging Antiplatelet Therapy With Cangrelor 2 Study

University of Florida Jacksonville

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.